Julián Torre‐Cisneros

机构：Instituto de Salud Carlos III, Instituto Maimónides de Investigación Biomédica de Córdoba, Centro de Investigación Biomédica en Red, Hospital Universitario Reina Sofía · ORCID：0000-0003-1529-6302

发表论文 228 篇 · 总被引 10141 次 · h-index 48

代表论文

• Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial (2024 · The Lancet Infectious Diseases · 被引 115)
• A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response (2024 · Clinical Infectious Diseases · 被引 35)
• Effectiveness and safety of cefiderocol treatment in patients with Gram-negative bacterial infections in Spain in the early access programme: results of the PERSEUS study (2025 · European Journal of Clinical Microbiology & Infectious Diseases · 被引 27)
• Cefiderocol treatment for patients infected by Stenotrophomonas maltophilia, Burkholderia cepacia complex and Achromobacter spp.: subgroup analysis from the PERSEUS study (2025 · European Journal of Clinical Microbiology & Infectious Diseases · 被引 16)
• Identification and validation of clinical phenotypes in Staphylococcus aureus bloodstream infection and their association with mortality (FEN-AUREUS study) (2025 · EClinicalMedicine · 被引 10)
• Hurdles for the Delivery of Multinational Randomized Clinical Trials (2025 · JAMA Network Open · 被引 9)